Evolv Technologies Holdings Inc (EVLV)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Evolv Technologies Holdings Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 8 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 5.50 $ — 15% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
6 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 40.4% passed
- More than 10% revenue growth is expected for the coming year 18.1% passed
- Share count grows by less than 3% a year 5.4% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 31.8% failed
- Gross margin at 40% or higher and without meaningful erosion 51.6% passed
- Goodwill from acquisitions does not grow faster than revenue 0.0% passed
- Net debt below twice EBITDA 27 m net cash passed
- Operating cash flow covers the profits of the last three years 171 m passed
- Return on capital at 15% or higher, or up versus two years ago -24.7% failed
- Insiders hold at least 10% or are net buyers 4.3% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 84.2% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 4
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.06 | -0.08 – -0.04 | 177 | 36.7% | 3 |
| 12/31/2027 | -0.03 | -0.04 – -0.02 | 209 | 52.6% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.06 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.10 | – | 29 | 33.40 | -54.00 | 3 | -5 |
| 2025: Q1 | -0.01 | – | 32 | 44.30 | -5.30 | -3 | -17 |
| 2025: Q2 | -0.25 | -1,315.60 | 33 | 27.40 | -124.60 | 2 | -2 |
| 2025: Q3 | -0.01 | – | 43 | 56.60 | -4.20 | 4 | -12 |
| 2025: Q4 | 0.06 | – | 39 | 32.30 | 28.30 | 16 | 9 |
| 2026: Q1 | -0.03 | – | 46 | 44.70 | -10.80 | -3 | -8 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2019 | 6 | -18 | -20 | -0.14 | -15 | -59 | 24 |
| 2020 | 5 | -27 | -27 | -3.07 | -23 | -85 | 21 |
| 2021 | 23 | -55 | -11 | -0.07 | -57 | 290 | 363 |
| 2022 | 53 | -103 | -87 | -0.60 | -75 | 227 | 348 |
| 2023 | 80 | -88 | -106 | -0.71 | -10 | 146 | 299 |
| 2024 | 104 | -82 | -54 | -0.35 | -31 | 118 | 268 |
| 2025 | 146 | -45 | -33 | -0.20 | 19 | 119 | 304 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Evolv Technologies Holdings, Inc. entwickelt, fertigt, vermarktet und verkauft Sicherheitsscreening-Produkte und spezifische Dienstleistungen in den USA und international.
| Employees | 286 |
|---|---|
| Headquarters | Waltham, MA |
| Address | 500 Totten Pond Road, 02451 Waltham, United States |
| Phone | 781 374 8100 |
| Website | evolv.com |
| IPO Date | 22. Sep 2020 |
| ISIN | US30049H1023 |
Management
| Name | Title | Birth Year |
|---|---|---|
| John Kedzierski | President, CEO & Executive Director | 1979 |
| Michael Philip Ellenbogen | Co-Founder & Director | 1965 |
| George Chris Kutsor | Chief Financial Officer | 1973 |
| Robert E. Marshall Jr. | Chief Revenue Officer | 1972 |
| Anil R. Chitkara | Co-Founder & Chief Growth Officer | 1968 |
| Brian Norris | Senior Vice President of Finance and Investor Relations | – |
| Rachel Roy | General Counsel & Chief Compliance Officer | – |
| Alexandra Smith Ozerkis | Chief Marketing Officer | – |
| Liza Knapp | Head of People | – |
| Owais Hassan | Chief of Engineering | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 15. Jul 2026 | Ellenbogen Michael | Director | Sell | 80,745 | 5.94 | 479,625 |
| 15. Jul 2026 | Ellenbogen Michael | Director | Other | 80,745 | 0.24 | 19,379 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.